Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Int J Cardiol ; 67(2): 143-6, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9891947

ABSTRACT

This study aimed at determining risk factors for perioperative mortality for patients undergoing partial left ventriculectomy. Fourteen patients with end-stage congestive heart failure underwent partial ventriculectomy at our institution from February, 1995 to October, 1997. Mean age was 48+/-11 years, symptoms duration 44+/-34 months, New York Heart Association symptoms score 4+/-0, systolic blood pressure 97.69+/-20.06 mmHg, diastolic blood pressure 65.38+/-13.91 mmHg, heart rate 91+/-15 beats/min, furosemide daily dose 121.66+/-96.65 mg and captopril daily dose 68.75+/-76.76 mg. Seven (50%) patients needed inotropic support for hemodynamic stabilization. On echocardiography, left ventricular diastolic dimension was 81.71+/-11.92 mm. Left ventricular ejection fraction determined by radionuclide ventriculography or echocardiography was 16.71+/-5.13. At heart catheterization, mean right atrial pressure was 12.50+/-7.72 mmHg, mean pulmonary capillary wedge pressure 23.60+/-7.79 mmHg, and mean pulmonary artery pressure 34.10+/-12.81 mmHg. Twelve patients had idiopathic dilated cardiomyopathy and two patients had a globally dilated heart with single vessel coronary artery disease. Aneurysmectomy, mitral valve surgery or coronary artery bypass surgery were not performed in any patient. Four (28%) patients died: three in the operating theatre and one from low output syndrome 2 days after surgery. The proportion of patients operated on with cardiogenic shock was four (100%) in nonsurvivors and 0% in survivors (P=0.001). Inotropic support was necessary in three (30%) survivors and in four (100%) nonsurvivors (P=0.06). Thus, preoperative hemodynamic instability may be associated with perioperative mortality after partial left ventriculectomy.


Subject(s)
Cardiac Surgical Procedures/methods , Heart Failure/surgery , Heart Ventricles/surgery , Adult , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Captopril/therapeutic use , Cardiac Surgical Procedures/adverse effects , Cardiomyopathy, Dilated/complications , Cardiomyopathy, Dilated/drug therapy , Cardiomyopathy, Dilated/surgery , Diuretics/therapeutic use , Echocardiography , Electrocardiography , Enalapril/therapeutic use , Female , Furosemide/therapeutic use , Heart Failure/complications , Heart Failure/drug therapy , Hemodynamics , Humans , Male , Middle Aged , Perioperative Care , Postoperative Complications/etiology , Postoperative Complications/mortality , Preoperative Care , Risk Factors , Shock, Cardiogenic/complications
4.
Arq Bras Cardiol ; 68(6): 397-400, 1997 Jun.
Article in Portuguese | MEDLINE | ID: mdl-9515246

ABSTRACT

OBJECTIVE: To assess the efficacy of partial left ventriculectomy as a treatment for patients with end-stage heart failure. METHODS: From February to June 1995, 7 patients with end-stage heart failure underwent partial left ventriculectomy. Subsequently, patients underwent clinical evaluation every 2 months, and 2-dimensional echocardiography at the 6th and 12th months after cardiac surgery. All patients were given digitalis and diuretics at conventional doses, and captopril or enalapril at maximal tolerated doses. RESULTS: Two (28%) patients died; 1 from cardiac arrhythmia associated with gastrointestinal hemorrhage, and the other suddenly. One (14%) patient developed an embolic cerebrovascular accident. Four (57%) patients were hospitalized for congestive heart failure; all of them had either decreased the daily dose of captopril or enalapril or discontinued the drugs by themselves. Twelve months after ventriculectomy, left ventricular ejection fraction values were greater and left ventricular diastolic dimension and functional class values lower than those found before cardiac operation. CONCLUSION: Beneficial effects of partial left ventriculectomy are observed one year after the surgical procedure. This technique, therefore, can be useful for the treatment of patients with end-stage heart failure.


Subject(s)
Cardiac Surgical Procedures/methods , Heart Failure/surgery , Heart Ventricles/surgery , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Captopril/therapeutic use , Enalapril/therapeutic use , Follow-Up Studies , Heart Failure/drug therapy , Humans , Terminally Ill
6.
Arq Bras Cardiol ; 66(4): 189-92, 1996 Apr.
Article in Portuguese | MEDLINE | ID: mdl-8935682

ABSTRACT

PURPOSE: To evaluate the efficacy of left ventriculectomy, on a short term basis, as a treatment for patients with end-stage heart failure. METHODS: From February to June 1995, 7 patients with end-stage heart failure underwent partial left ventriculectomy. Before the surgical procedure, 7 (100%) patients were in functional class IV. Three (42%) patients needed inotropic support for hemodynamic stability. The mean daily dose of furosemide was l48.67 +/- 128.27 mg, of captopril 87.50 +/- 95.20 mg and of digoxin 0.23 +/- 0.04. Mean left ventricular diastolic dimension determined by 2-D echocardiography was 78.29 +/- 12.63 mm, mean left ventricular ejection fraction, determined by radionuclide ventriculography, was 0.15 +/- 0.05 whereas mean transpulmonary gradient and pulmonary vascular resistance in Wood units, determined by right heart catheterization, were 16.80 +/- 8.80 and 6.57 +/- 3.22, respectively. RESULTS: Sixty days after the surgery, the mean functional class was 1.71 +/- 0.48 (p = 0.009), the mean left ventricular diastolic dimension 64.67 +/- 11.41 mm (p = 0.02) and the mean left ventricular ejection fraction 0.22 +/- 0.04 (p = 0.02). CONCLUSION: The left ventriculectomy is a promising treatment for patients with end-stage heart failure.


Subject(s)
Cardiac Surgical Procedures/methods , Heart Failure/surgery , Heart Ventricles/surgery , Echocardiography, Doppler , Humans , Male , Postoperative Period , Radionuclide Ventriculography , Stroke Volume , Treatment Outcome
7.
J Cardiovasc Surg (Torino) ; 28(2): 143-4, 1987.
Article in English | MEDLINE | ID: mdl-3558462

ABSTRACT

The authors present a mechanical system for pulsatile cardiopulmonary bypass. Its major advantages are: simplicity, low cost and the synchronization of pulse generation with the arterial roller. This system has been used clinically since 1981.


Subject(s)
Heart-Lung Machine , Evaluation Studies as Topic , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...